These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17645086)

  • 1. [The role of muscarinic receptor antagonists in the treatment of men with lower urinary tract symptoms secondary to BPH].
    Kaplan SA
    Actas Urol Esp; 2007 Feb; 31(2):86-91. PubMed ID: 17645086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia.
    Chapple C
    Curr Opin Urol; 2010 Jan; 20(1):43-8. PubMed ID: 19875964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of antimuscarinics in patients with lower urinary tract symptoms for BPH and overactive bladder].
    Ruiz Cerdá JL
    Actas Urol Esp; 2006 Oct; 30(9):849-55. PubMed ID: 17175924
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of antimuscarinics in patients with LUTS-BPH and OAB symptoms: clinical expertise and resistance to lose the fear to urinary retention risk].
    Ruiz Cerdá JL
    Actas Urol Esp; 2008; 32(10):957-60. PubMed ID: 19143285
    [No Abstract]   [Full Text] [Related]  

  • 6. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
    Hakimi Z; Johnson M; Nazir J; Blak B; Odeyemi IA
    Curr Med Res Opin; 2015 Jan; 31(1):43-50. PubMed ID: 25333647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role for combination therapy in male LUTS.
    Chung DE; Kaplan SA
    Arch Esp Urol; 2010 Jun; 63(5):323-32. PubMed ID: 20587837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
    Barkin J; Diles D; Franks B; Berner T
    Can J Urol; 2015 Aug; 22(4):7914-23. PubMed ID: 26267031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.
    Kaplan SA; Roehrborn CG; Abrams P; Chapple CR; Bavendam T; Guan Z
    Int J Clin Pract; 2011 Apr; 65(4):487-507. PubMed ID: 21210910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
    Silva J; Silva CM; Cruz F
    Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of the lower urinary tract symptoms secondary to benign prostatic hyperplasia by phosphodiesterase type 5 inhibitors. Review article].
    Caremel R; Oger-Roussel S; Behr-Roussel D; Grise P; Giuliano F
    Prog Urol; 2010 Oct; 20(9):616-26. PubMed ID: 20951929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
    Chapple CR; Roehrborn CG
    Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When to use antimuscarinics in men who have lower urinary tract symptoms.
    Lee JY; Kim DK; Chancellor MB
    Urol Clin North Am; 2006 Nov; 33(4):531-7, x. PubMed ID: 17011389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment and prognostic factors of alpha 1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: a pilot study comparing naftopidil and tamsulosin hydrochloride.
    Kawachi Y; Sakurai T; Sugimura S; Iwata S; Noto K; Honda S; Maruyama O
    Scand J Urol Nephrol; 2010 Feb; 44(1):38-45. PubMed ID: 20095868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia.
    Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
    J Pharmacol Sci; 2015 Jun; 128(2):65-70. PubMed ID: 26084660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.